45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
4,848
Insurances with rates
3
CPT / HCPCS codes
2,687
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J7181 | TRETTEN 2,500 UNIT INTRAVENOUS SOLUTION | $369,210 | $369,210 | — | — | 10 |
| J2326 | SPINRAZA (PF) 12 MG/5 ML INTRATHECAL SOLUTION | $333,562 | $333,562 | — | — | 5 |
| Q2043 | PROVENGE 50 MILLION CELL/250 ML INTRAVENOUS SUSPENSION | $289,537 | $289,537 | — | — | 5 |
| J0225 | AMVUTTRA 25 MG/0.5 ML SUBCUTANEOUS SYRINGE | $272,120 | $272,120 | — | — | 5 |
| J9347 | IMJUDO 20 MG/ML INTRAVENOUS SOLUTION | $269,803 | $269,803 | — | — | 10 |
| J2351 | OCREVUS ZUNOVO 920 MG-23,000 UNIT/23 ML SUBCUTANEOUS SOLUTION | $193,199 | $193,199 | — | — | 5 |
| J1823 | UPLIZNA 10 MG/ML INTRAVENOUS SOLUTION | $150,672 | $150,672 | — | — | 10 |
| J9999 | GLIADEL WAFER 7.7 MG IMPLANT | $131,789 | $131,789 | — | — | 5 |
| J2350 | OCREVUS 30 MG/ML INTRAVENOUS SOLUTION | $131,277 | $131,277 | — | — | 5 |
| J9226 | SUPPRELIN LA 50 MG (65 MCG/DAY) IMPLANT KIT | $114,414 | $114,414 | — | — | 5 |
| 0915T | Insj Perm Ccm-D Sys Pg&Eltrd | $105,273 | $105,273 | — | — | 5 |
| C9293 | VORAXAZE 1,000 UNIT INTRAVENOUS SOLUTION | $98,571 | $98,571 | — | — | 5 |
| J1628 | TREMFYA 200 MG/20 ML (10 MG/ML) INTRAVENOUS SOLUTION | $92,643 | $92,643 | — | — | 10 |
| J9028 | ANKTIVA 400 MCG/0.4 ML INTRAVESICAL SOLUTION | $81,624 | $81,624 | — | — | 5 |
| J9269 | ELZONRIS 1,000 MCG/ML INTRAVENOUS SOLUTION | $76,965 | $76,965 | — | — | 5 |
| 0916T | Insj Perm Ccm-D Sys Pg Only | $73,700 | $73,700 | — | — | 5 |
| 0923T | Rmvl&Rplcmt Perm Ccm-D Pg | $73,700 | $73,700 | — | — | 5 |
| J2507 | KRYSTEXXA 8 MG/ML INTRAVENOUS SOLUTION | $72,477 | $72,477 | — | — | 5 |
| J9334 | VYVGART HYTRULO 1,000 MG-10,000 UNIT/5 ML SUBCUTANEOUS SYRINGE | $70,274 | $70,274 | — | — | 10 |
| J0202 | LEMTRADA 12 MG/1.2 ML INTRAVENOUS SOLUTION | $67,817 | $67,817 | — | — | 5 |
| J9345 | ZYNYZ 500 MG/20 ML INTRAVENOUS SOLUTION | $66,769 | $66,769 | — | — | 5 |
| J9359 | ZYNLONTA 10 MG INTRAVENOUS SOLUTION | $66,188 | $66,188 | — | — | 5 |
| J1246 | UNITUXIN 3.5 MG/ML INTRAVENOUS SOLUTION | $65,311 | $65,311 | — | — | 5 |
| J9316 | PHESGO 1,200 MG-600 MG-30,000 UNIT/15 ML SUBCUTANEOUS SOLUTION | $65,129 | $65,129 | — | — | 5 |
| J0222 | ONPATTRO 2 MG/ML INTRAVENOUS SOLUTION | $62,233 | $62,233 | — | — | 5 |
| J2267 | OMVOH 300 MG/15 ML (20 MG/ML) INTRAVENOUS SOLUTION | $61,013 | $61,013 | — | — | 5 |
| J2323 | TYSABRI 300 MG/15 ML INTRAVENOUS SOLUTION | $56,472 | $56,472 | — | — | 5 |
| J9229 | BESPONSA 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) INTRAVENOUS SOLUTION | $55,619 | $55,619 | — | — | 5 |
| J2329 | BRIUMVI 25 MG/ML INTRAVENOUS SOLUTION | $55,374 | $55,374 | — | — | 5 |
| J9272 | JEMPERLI 50 MG/ML INTRAVENOUS SOLUTION | $54,483 | $54,483 | — | — | 5 |
| J2327 | SKYRIZI 360 MG/2.4 ML (150 MG/ML) SUBCUTANEOUS WEARABLE INJECTOR | $54,352 | $54,352 | — | — | 10 |
| C1767 | Generator, Neurostimulator(Imp) | $53,800 | $53,800 | — | — | 5 |
| J3316 | TRIPTODUR 22.5 MG IM SUSPENSION | $52,364 | $52,364 | — | — | 10 |
| J9022 | TECENTRIQ 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION | $51,457 | $51,457 | — | — | 5 |
| J9024 | TECENTRIQ HYBREZA 1,875 MG-30,000 UNIT/15 ML SUBCUTANEOUS SOLUTION | $51,457 | $51,457 | — | — | 5 |
| J0638 | ILARIS (PF) 150 MG/ML SUBCUTANEOUS SOLUTION | $51,121 | $51,121 | — | — | 5 |
| J9119 | LIBTAYO 50 MG/ML INTRAVENOUS SOLUTION | $50,326 | $50,326 | — | — | 5 |
| J7198 | FEIBA NF 1,750 UNIT-3,250 UNIT INTRAVENOUS SOLUTION | $50,220 | $50,220 | — | — | 10 |
| 81416 | Xomedx Plus Trio, Ref | $50,140 | $50,140 | — | — | 5 |
| J2502 | SIGNIFOR LAR 40 MG IM SUSPENSION | $49,610 | $49,610 | — | — | 5 |
| J9274 | KIMMTRAK 100 MCG/0.5 ML INTRAVENOUS SOLUTION | $49,043 | $49,043 | — | — | 5 |
| J9144 | DARZALEX FASPRO 1,800 MG-30,000 UNIT/15 ML SUBCUTANEOUS SOLUTION | $46,939 | $46,939 | — | — | 5 |
| J1323 | ELREXFIO 40 MG/ML SUBCUTANEOUS SOLUTION | $46,356 | $46,356 | — | — | 20 |
| J7185 | XYNTHA SOLOFUSE 3,000 (+/-) UNIT INTRAVENOUS SYRINGE | $43,710 | $43,710 | — | — | 10 |
| J3263 | LOQTORZI 240 MG/6 ML (40 MG/ML) INTRAVENOUS SOLUTION | $43,322 | $43,322 | — | — | 5 |
| J3241 | TEPEZZA 500 MG INTRAVENOUS SOLUTION | $42,685 | $42,685 | — | — | 5 |
| J9309 | POLIVY 140 MG INTRAVENOUS SOLUTION | $42,434 | $42,434 | — | — | 5 |
| J9600 | PHOTOFRIN 75 MG INTRAVENOUS SOLUTION | $42,417 | $42,417 | — | — | 5 |
| J1299 | SOLIRIS 300 MG/30 ML INTRAVENOUS SOLUTION | $41,486 | $41,486 | — | — | 5 |
| J3245 | ILUMYA 100 MG/ML SUBCUTANEOUS SYRINGE | $40,952 | $40,952 | — | — | 10 |
Showing top 50 of 4,848 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.